194 related articles for article (PubMed ID: 27801486)
1. Focal segmental glomerulosclerosis in children.
Jellouli M; Abidi K; Askri M; Ferjani M; Naija O; Hammi Y; Goucha R; Gargah T
Tunis Med; 2016 May; 94(5):356-359. PubMed ID: 27801486
[TBL] [Abstract][Full Text] [Related]
2. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and pathological characteristics of focal segmental glomerulosclerosis in children].
Huang JP; Zhang JJ; Liu JC; Chen YN; Yao Y; Xiao HJ; Yang JY
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):516-9. PubMed ID: 15324571
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and outcome of focal segmental glomerulosclerosis in Iranian children with nephrotic syndrome.
Hoseini R; Otukesh H; Fereshtehnejad SM; Tahoori A; Hooman N; Rahimzadeh N; Sadr S
Iran J Kidney Dis; 2012 Jan; 6(1):18-24. PubMed ID: 22218115
[TBL] [Abstract][Full Text] [Related]
6. A clinicopathologic study of primary focal segmental glomerulosclerosis in children.
Lanewala A; Mubarak M; Kazi JI; Akhter F; Sher A; Fayyaz A; Bhatti S
Saudi J Kidney Dis Transpl; 2012 May; 23(3):513-20. PubMed ID: 22569437
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F; Ahmad TM; Anwar S
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.
Martinelli R; Pereira LJ; Silva OM; Okumura AS; Rocha H
Braz J Med Biol Res; 2004 Sep; 37(9):1365-72. PubMed ID: 15334202
[TBL] [Abstract][Full Text] [Related]
10. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
[No Abstract] [Full Text] [Related]
11. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
12. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
Beşbaş N; Ozaltin F; Emre S; Anarat A; Alpay H; Bakkaloğlu A; Baskin E; Buyan N; Dönmez O; Düşünsel R; Ekim M; Göko F; Gür-Güven A; Kavukçu S; Mir S; Sönmez F
Turk J Pediatr; 2010; 52(3):255-61. PubMed ID: 20718182
[TBL] [Abstract][Full Text] [Related]
13. Primary focal segmental glomerulosclerosis in children: prognostic factors.
Martinelli R; Okumura AS; Pereira LJ; Rocha H
Pediatr Nephrol; 2001 Aug; 16(8):658-61. PubMed ID: 11519897
[TBL] [Abstract][Full Text] [Related]
14. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
Drube J; Geerlings C; Taylor R; Mengel M; Ehrich JH
Pediatr Nephrol; 2007 Apr; 22(4):600-2. PubMed ID: 17235550
[TBL] [Abstract][Full Text] [Related]
15. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
Geary DF; Farine M; Thorner P; Baumal R
Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
[TBL] [Abstract][Full Text] [Related]
17. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
[TBL] [Abstract][Full Text] [Related]
18. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S
G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis.
Alexopoulos E; Stangou M; Papagianni A; Pantzaki A; Papadimitriou M
Nephrol Dial Transplant; 2000 Sep; 15(9):1348-56. PubMed ID: 10978390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
